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Selection of resistance in Spodoptera exigua (Hu¨bner) to an HD-1 spore-crystal mixture, CryIC (HD-133)
inclusion bodies, and trypsinized toxin from Bacillus thuringiensis subsp. aizawai and B. thuringiensis subsp.
entomocidus was attempted by using laboratory bioassays. No resistance to the HD-1 spore-crystal mixture
could be achieved after 20 generations of selection. Significant levels of resistance (11-fold) to CryIC inclusion
bodies expressed in Escherichia coli were observed after seven generations. Subsequent selection of the CryIC-
resistant population with trypsinized CryIC toxin resulted, after 21 generations of CryIC selection, in a
population of S. exigua that exhibited only 8% mortality at the highest toxin concentration tested (320 mg/g),
whereas the 50% lethal concentration was 4.30 mg/g for the susceptible colony. Insects resistant to CryIC toxin
from HD-133 also were resistant to trypsinized CryIA(b), CryIC from B. thuringiensis subsp. entomocidus,
CryIE-CryIC fusion protein (G27), CryIH, and CryIIA. In vitro binding experiments with brush border
membrane vesicles showed a twofold decrease in maximum CryIC binding, a fivefold difference in Kd, and no
difference in the concentration of binding sites for the CryIC-resistant insects compared with those for the
susceptible insects. Resistance to CryIC was significantly reduced by the addition of HD-1 spores. Resistance
to the CryIC toxin was still observed 12 generations after CryIC selection was removed. These results suggest
that, in S. exigua, resistance to a single protein is more likely to occur than resistance to spore-crystal mixtures
and that once resistance occurs, insects will be resistant to many other Cry proteins. These results have
important implications for devising S. exigua resistance management strategies in the field.
Use of microbial insecticides based on Bacillus thuringiensis
is expected to increase considerably in the future because of
escalating environmental concerns over the use of synthetic
insecticides. Resistance to B. thuringiensis in the field is a major
concern associated with increased usage (see Tabashnik [28]
for a review). Spodoptera exigua (Hu¨bner) (Lepidoptera: Noc-
tuidae) is a cosmopolitan pest on many economically impor-
tant crops. Historically, formulations of B. thuringiensis subsp.
kurstakiHD-1 applied at recommended field rates usually were
not efficacious against S. exigua (32). Formulations of HD-1
typically contain CryIA(a), CryIA(b), CryIA(c), and CryIIA
proteins (terminology after Ho¨fte and Whiteley [9]), all of
which have relatively low levels of toxicity to S. exigua (15, 17).
Therefore, high selection pressure for physiological resistance
would not be expected to occur against S. exigua. Products
containing CryIC (the most active B. thuringiensis d-endotoxin
against Spodoptera spp.) have recently been developed and
targeted for commercial use against S. exigua (9, 13, 15, 35).
Xentari (Abbott Laboratories, North Chicago, Ill.) is a B. thu-
ringiensis subsp. aizawai-based product containing CryIC that is
more than sevenfold more toxic against S. exigua than B. thu-
ringiensis subsp. kurstaki-type products (e.g., Dipel 2X) (14).
As the toxicity and use of new materials formulated from B.
thuringiensis or transgenic organisms expressing B. thuringiensis
proteins against S. exigua increase, concern for the develop-
ment of resistance also should increase.
Lepidopteran resistance to B. thuringiensis has been known
since 1985, but only in a few taxonomic families (28). Resis-
tance to B. thuringiensis in Plodia interpunctella (Hu¨bner)
(Pyralidae) and Plutella xylostella (L.) (Plutellidae) has been
associated with a reduction in toxin binding (6, 34). Nonethe-
less, these insects were susceptible to other B. thuringiensis
toxins (31, 34). Gould et al. (8) reported broad-spectrum re-
sistance to B. thuringiensis toxins in Heliothis virescens (F.)
(Noctuidae). In this insect, resistance to CryIA(c) conferred
resistance to CryIA(a), CryIA(b), CryIB, CryIC, and CryIIA.
Furthermore, there were no significant changes in toxin bind-
ing. Recently, Estada and Ferre (5) reported that a strain of
Trichoplusia ni (Hu¨bner) (Noctuidae) was resistant to
CryIA(b) but was still susceptible to CryIA(c), even though
both proteins seemed to share the same high-affinity binding
site. Clearly, resistance to Cry proteins cannot be generalized,
and additional studies of resistance are needed.
The objective of our studies was to determine if resistance to
B. thuringiensis could be selected for in S. exigua by using
spore-crystal mixtures and a single d-endotoxin. S. exigua is in
the same taxonomic family (Noctuidae) as H. virescens and T.
ni, so the results from our study can be used to increase our
understanding of resistance within a taxonomic family. Infor-
mation on the likelihood and rate of resistance development,
the possibility of cross-resistance, and the rate of reversion to
susceptible status after selection pressure has been removed
will allow us to develop specific resistance management strat-
egies to reduce the threat of B. thuringiensis resistance in S.
exigua.
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We report here that high levels of resistance to CryIC by S.
exigua have been achieved in a laboratory experimental system.
Resistance cannot be totally explained by toxin binding. Resis-
tance to CryIC results in broad-spectrum resistance to all other
B. thuringiensis toxins tested. When selection pressure with
CryIC is removed, resistance to CryIC is stable for at least 10
generations. Additionally, purified spores from HD-1 act in
synergy with CryIC toxin against resistant S. exigua.
MATERIALS AND METHODS
Insect colony. An S. exigua colony was established at Auburn University with
insects collected from cotton prior to the initiation of the study. An additional 10
to 20 S. exigua egg masses were collected in 1991 from the Wiregrass Substation,
Headland, Henry County, Ala, and were introduced into the laboratory colony
just before our study was begun. The colony was reared on an artificial diet (4)
at 28 6 18C with a photoperiod of 16:8 h (light:dark).
Bacterial strains, plasmids, and culturing. B. thuringiensis subsp. kurstaki
HD-1 was obtained from L. Masson, National Research Council, Ottawa, On-
tario, Canada. This strain contains all three cryIA genes associated with HD-1
(15). Escherichia coli strains containing the cryIA(b) gene from B. thuringiensis
subsp. kurstaki HD-1 and the cryIC gene from B. thuringiensis subsp. aizawai
HD-133 were obtained from L. Masson, National Research Council, Canada.
The cryIC gene from B. thuringiensis subsp. entomocidus 60.5 was inserted into
the Bacillus-E. coli shuttle vector pHT3101 and was transformed into an acrys-
talliferous strain of HD-1 [HD-1 (Cry2)] (10). Trypsinized CryIC from B. thu-
ringiensis subsp. entomocidus 60.5 and a trypsinized CryIE-CryIC fusion protein
(G27) were obtained as described by Bosch et al. (3). Trypsinized CryIH was
obtained from Plant Genetic Systems, Ghent, Belgium. CryIIA inclusion bodies
were obtained from an NRD-12 cryIIA gene expressed in E. coli BL21(lDE3)
(17).
Cultures of HD-1 were grown in a glucose, yeast, and salts medium (16). All
E. coli strains containing cry genes were grown in Terrific broth in the presence
of ampicillin, and inclusion bodies were purified (17). The HD-1 (Cry2) strain
containing the cryIC gene from B. thuringiensis subsp. entomocidus was grown in
nutrient broth in the presence of erythromycin, and inclusion bodies were puri-
fied (17).
Protein concentrations for CryIC (38.14 mg/ml) and CryIIA (86.65 mg/ml)
inclusion bodies were determined by the Micro BCA Protein Assay (Pierce
Chemical Co., Rockford, Ill.). The purities of the protoxins were estimated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. For toxin purifica-
tion, CryIA(b) and CryIC inclusion bodies were digested without previous sol-
ubilization by using 50 mM CAPs buffer (pH 10.5) containing 1 mg of bovine
pancreas trypsin (Sigma Chemical Co., St. Louis, Mo.) per ml. Trypsinized toxins
were purified and isolated by high-pressure liquid chromatography (22).
Spore purification. Purification of HD-1 spores from sporulated cultures was
performed as described by Moar et al. (16). Spore preparations were estimated
to contain fewer than 1.0% bipyramidal crystals by volume as observed under the
stereomicroscope (a minimum of 1,000 bipyramidal crystals were examined).
Insect toxicity assays. Initial bioassays were conducted to determine the rel-
ative sensitivity of S. exigua to HD-1 spores-crystals and CryIC inclusion bodies.
Seven to eight concentrations were assayed against neonate S. exigua by diet
incorporation assays. Toxin was added to 16 ml of artificial diet (4), and the
mixture was poured into a 24-well bioassay tray. One or two neonates were
loaded per well. Trays were placed at 28 6 18C with a photoperiod of 16:8 h
(light:dark). Mortality was recorded after 7 days. Mortality of controls was
,10%. Assays were replicated three to four times. Data were analyzed by probit
analysis (25).
Large-scale bioassays similar to those described above were conducted for the
selection experiments. Surviving individuals from concentrations representing
the 5 to 10% lethal concentration (LC5–10) were removed after 5 days on the
treated diet and were transferred to an untreated diet to complete development
or for use as fifth instars for binding studies (CryIC toxin population only). Every
subsequent generation was selected by using either the same or a twofold greater
concentration compared with that used with the previous generation. S. exigua
populations resistant to CryIC inclusion bodies were divided into two groups for
subsequent selection with CryIC inclusion bodies and trypsinized protein (sub-
sequently referred to as toxin) beginning at generation 14. Selection with CryIC
inclusion bodies was continued until generation 16. Selection with CryIC toxin
was maintained exclusively at 320 mg of toxin per g of diet beginning with
generation 17. After bioassays determined that the S. exigua population resistant
to HD-133 CryIC toxin was also resistant to the CryIC toxin from B. thuringiensis
subsp. entomocidus 60.5, populations were selected exclusively with B. thurin-
giensis subsp. entomocidus 60.5 beginning at generation 32 because of the in-
creased level of expression and ease of extracting the CryIC from B. thuringiensis
subsp. entomocidus.
At selected generations, susceptible and resistant larvae were bioassayed con-
currently to determine the levels of resistance to HD-1, CryIC inclusion bodies,
or CryIC toxin. When the reversion (see section on stability of resistance)
population was available, susceptible, resistant, and reversion populations were
bioassayed with the CryIC toxin. Five concentrations were typically used for
susceptible insects, whereas one to nine concentrations were used for resistant
and reversion insects. At least three replicates were performed per resistant
generation when larvae from all three populations were available; however,
toxicity data from one to two replicates also were included for several genera-
tions. Otherwise, bioassays were performed as discussed above. Resistance ratios
(RRs) were calculated between resistant and susceptible populations or rever-
sion and susceptible populations. The RR was defined as the LC50 for the
resistant or reversion population divided by the LC50 for the susceptible popu-
lation. When the highest concentration tested for the resistant or reversion
colony did not result in at least 50% mortality, the RR was calculated as if the
LC50 for the resistant or reversion population equaled the highest concentration
tested divided by the LC50 for the susceptible population.
Bioassays conducted with other Cry toxins (cross-resistance bioassays) usually
were performed with two to six and one to six concentrations for susceptible and
CryIC-resistant S. exigua, respectively. Bioassays were performed concurrently
with both populations and were replicated only two or three times because of
limited quantities of material and the relatively high concentrations required.
Joint-action bioassays with single concentrations of HD-133 CryIC toxin,
CryIIA, and HD-1 spores were conducted concurrently with resistant insects
from generation 35 and susceptible insects. Bioassays were replicated three
times. Joint-action bioassay data were analyzed by a x2 test (23).
Preparation of BBMVs and binding assays. Full-length guts from fifth instar
susceptible or CryIC-resistant S. exigua larvae were removed in ice-cold MET
buffer (17 mM Tris HCl [pH 7.6], 5 mM EGTA [ethylene glycol-bis(p-aminoethyl
ether)-N,N,N9,N9-tetraacetic acid], 300 mMmannitol) and were stored at2758C.
Gut tissue was thawed, and brush border membrane vesicles (BBMVs) were
prepared as described by Luo and Adang (11). CryIC toxin was purified and
iodinated with Na125I (11). The specific activity of CryIC was 11 mCi/mg of input
toxin. Two separate binding experiments were performed with tissue from resis-
tant generations 24 and 27, representing RRs of 100 and .500, respectively.
Binding assays were performed by the method of Garczynski et al. (7). In the
competition experiments, the reaction mixtures contained 80 and 100 mg of
BBMV proteins per ml from CryIC-resistant and susceptible S. exigua, respec-
tively, and 0.1 nM 125I-labeled CryIC toxin, plus increasing concentrations of
unlabeled toxins. Data were analyzed by the LIGAND computer program (19).
Stability of resistance to CryIC. A new population of S. exigua larvae was
established from the CryIC-resistant survivors of generation 29 on CryIC at 320
mg of toxin per g of diet. These insects were reared on untreated diet as described
above. Neonate larvae (reversion 1) from the adult survivors of generation 29
were placed on untreated diet and grown to pupation. This procedure was
repeated for 12 generations. Bioassays were conducted at selected generations of
the reversion population to determine levels of resistance to CryIC.
RESULTS
Selection for resistance. RRs of S. exigua to the HD-1 strain
ranged from 1.09 to 2.22 for selected generations 20 and 11,
respectively (Table 1). These bioassays were conducted on
generations that were continuously selected with the HD-1
spore-crystal mixture. All eggs laid by adults from generation
22 were sterile, so the study was discontinued.
Elevenfold resistance to the E. coli-expressed HD-133 CryIC
TABLE 1. S. exigua resistance to the HD-1 spore-crystal mixture
of B. thuringiensis
Generationa nb LC50(95% FL)c
Slope
(mean 6 SE) RR
d
10 157 144 (102–190) 1.91 6 0.29 1.98
Susc. 129 73 (51–94) 2.65 6 0.48
11 187 98 (7–306) 0.95 6 0.28 2.22
Susc. 190 44e 0.92 6 0.46
20 51 254 (161–446) 2.19 6 0.54 1.09
Susc. 88 232e 1.76 6 0.58
a Generation of S. exigua continuously selected with HD-1. Susc., susceptible.
b Total number of insects tested (one replicate with three to six concentra-
tions).
c LC50s are in micrograms of HD-1 spore-crystal mixture per gram of diet. FL,
fiducial limits.
d LC50 for the selected generation divided by the LC50 for the susceptible
colony.
e Fiducial limits could not be generated.
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inclusion bodies was achieved after seven generations (LC50
for susceptible S. exigua, 9.2 mg/g; LC50 for resistant S. exigua,
100 mg/g). Interestingly, although selection continued, no con-
sistent increase in resistance was observed (data not shown).
Initial bioassays with CryIC toxin conducted with generation
14 of CryIC inclusion body-resistant S. exigua showed an RR of
7 (Table 2). However, continuous selection with CryIC toxin
resulted in a considerable decrease in mortality beginning with
generation 22 (RR 5 54). Increased resistance was observed
again at generation 25 (RR 5 850). Because of the limited
availability of CryIC toxin and the large concentrations re-
quired to establish LC50s with this highly resistant population,
only one concentration of CryIC toxin was used for bioassays
against the CryIC-resistant population beginning with genera-
tion 27. After 35 generations, only 8% mortality was observed
with the CryIC-resistant population at 320 mg of toxin per g of
diet, whereas the LC50 for susceptible S. exigua was 4.3 mg of
CryIC toxin per g of diet. Bioassays also were conducted with
HD-133 CryIC inclusion bodies against CryIC-resistant larvae
from generations 22 and 23. Even though these populations
were 54- and 86-fold more resistant to CryIC toxin, respec-
tively, they were only 11- and 12-fold more resistant to the
HD-133 CryIC inclusion bodies, respectively (Table 3).
CryIC-resistant S. exigua insects were resistant to all other
Cry proteins tested, including CryIA(b), CryIC from strain 60.5
of B. thuringiensis subsp. entomocidus, G27, CryIH, and CryIA
(Tables 4 and 5). However, the RRs presented in Tables 4 and
5 are not valid in most cases because (i) mortality of the CryIC
resistant insects was ,50% at the highest concentration tested
and (ii) limited quantities of the available Cry toxins did not
allow the generation of reliable LC50s of several of the Cry
toxins even for susceptible insects. Because HD-133 CryIC-
resistant S. exigua also was resistant to CryIC from B. thurin-
giensis subsp. entomocidus 60.5, this toxin replaced the HD-133
CryIC toxin for selection bioassays beginning with generation
29.
Binding. Binding experiments were performed with BBMVs
isolated from resistant generations 24 and 27 (representing
RRs of 100 and .500, respectively) and parallel control pop-
ulations. The results from both resistant samples were nearly
identical, and the data were pooled for analyses. Binding of
CryIC to BBMVs was reduced to about 50% of the normal
level in both CryIC-resistant populations. At concentrations of
about 150 mg of vesicle protein per ml, binding in the resistant
strain was 7%, compared with 13% in the susceptible strain
(Fig. 1A). Figure 1B shows the results of homologous compe-
tition experiments in which the amounts of 125I-labeled CryIC
and BBMVs were kept constant and the amount of unlabeled
CryIC was increased. The curve for the resistant insects was
shifted to the right, indicating a decrease in the affinity of the
binding sites for CryIC. Analyses by LIGAND estimated a Kd
of 1.5 nM for the susceptible larvae and a Kd of 8.5 nM for the
BBMVs from resistant insects. The concentration of high-af-
finity binding sites does not change, as indicated by similar
concentrations of binding sites (Bmax). Visual inspection of the
portion of the curves in Fig. 1B showing data for large excess
unlabeled toxin concentrations reveals a difference in binding
not subject to analysis by LIGAND. Unlabeled CryIC at 100
nM displaced 87% of the 125I-labeled CryIC in susceptible
insects but only 62% in the resistant insects. Together, the data
from the two types of binding experiments indicate that CryIC-
resistant insects have (i) an overall twofold decrease in total
CryIC binding, (ii) a fivefold decrease in the affinity of CryIC
for the high-affinity site, (iii) an increase in nonsaturable CryIC
binding, and (iv) unchanged binding site concentration.
Joint action. The addition of HD-1 spores (at a concentra-
tion causing only 4 to 6% mortality alone against resistant or
susceptible insects) resulted in a significant (P , 0.05) syner-
gistic interaction with either CryIC or CryIIA (Table 6). Syn-
ergism was observed for both CryIC-resistant and CryIC-sus-
ceptible S. exigua.
TABLE 2. S. exigua resistance to the CryIC toxin of B. thuringiensis
Generationa Nb LC50 (95% FL)c
Slope
(mean 6
SE)
RRd
14 662 41.2 (8.3–416) 0.70 6 0.18 7
Susc. 320 5.9 (1.0–18.8) 1.07 6 0.23
17 376 9.0 (4.0–15.3) 2.00 6 0.45 1.8
Susc. 391 4.9 (0.7–20.3) 1.76 6 0.56
22 153 209 (111–1612) 0.91 6 0.29 54
Susc. 187 3.9 (3.0–5.4) 1.76 6 0.22
23 755 165 (108–293) 0.75 6 0.08 86
Susc. 681 1.92 (0.8–3.6)e 1.35 6 0.25
25 569 544 (244–1963) 0.57 6 0.08 850
Susc. 411 0.6 (0.3–1.0) 0.92 6 0.11
27 326 21% mortality at 240 mg/g 0.22 6 0.32 (49)
Susc. 362 4.9 (3.9–6.4) 1.52 6 0.14
28 82 29% mortality at 640 mg/g 0.63 6 0.42 (291)
Susc. 348 2.2 (0.7–4.5) 1.03 6 0.21
29 205 25% mortality at 320 mg/g 0.59 6 0.40 (51)
Susc. 717 6.2 (5.3–7.4) 1.50 6 0.09
34 69 53% mortality at 320 mg/g NDe (330)
Susc. 477 1.0 (0.7–1.2) 2.12 6 0.22
35 178 8% mortality at 320 mg/g ND (75)
Susc. 515 4.3 (3.8–4.9) 2.36 6 0.18
a Generation of S. exigua continuously selected with CryIC toxin beginning
with generation 14. Susc., susceptible.
b Total number of insects tested (one to five replicates with one to nine
concentrations).
c LC50s are in micrograms of CryIC protoxin per gram of diet or percent
mortality at the highest concentration tested. FL, fiducial limits.
d LC50 for the selected generation divided by the LC50 for the susceptible
colony. Numbers in parentheses represent RRs when LC50 was assumed to be at
the highest concentration tested.
e ND, not determined.
TABLE 3. Resistance of CryIC-resistant S. exigua to B. thuringiensis
CryIC inclusion bodies expressed in E. coli
Generationa nb LC50(95% FL)c
Slope
(mean 6 SE) RR
d
22 320 293 (161–653) 0.84 6 0.13 11
Susc. 245 27 (13–51) 1.19 6 0.23
23 694 493 (292–1034) 0.64 6 0.07 12
Susc. 675 40 (33–49) 1.37 6 0.09
a Generation of S. exigua continuously selected with CryIC inclusion bodies for
generations 1 to 14 and then continuously selected with CryIC toxin. Susc.,
susceptible.
b Total number of insects tested (one to four replicates with four to nine
concentrations).
c LC50s are in micrograms of CryIC inclusion bodies per gram of diet. FL,
fiducial limits.
d LC50 for the selected generation divided by the LC50 for the susceptible
colony.
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Stability of resistance. CryIC-resistant S. exigua insects were
selected from generation 29 and were grown on the untreated
diet for subsequent generations. Significant resistance (RR .
10) was observed after 12 generations of culture on untreated
diet (Table 7). Because the insects from the 12th generation of
culture on untreated diet exhibited resistance (less than 50%
mortality) at the highest concentration tested (320 mg of toxin
per g of diet), a comparison could not be made to determine if
(or at what level) resistance had declined in comparison with
that in the CryIC-resistant population. However, results with
insects from generations 8 and 12 suggest that resistance was
declining in those populations.
DISCUSSION
Resistance to the HD-1 spore-crystal mixture could not be
accomplished after 20 generations of selection. Even though
HD-1 is relatively nontoxic to S. exigua, we conducted this
experiment because most B. thuringiensis products used against
S. exigua in the field are based on a B. thuringiensis subsp.
kurstaki strain (i.e., HD-1) and the only documented cases of
resistance in the field have been with products containing a B.
thuringiensis subsp. kurstaki strain (29). No development of
resistance has been reported with Spodoptera littoralis after 8
and 10 generations of laboratory selection with HD-1 (Dipel
2X) and B. thuringiensis subsp. entomocidus spore-crystal mix-
tures, respectively (24, 26).
The HD-1 spore-crystal mixture used for our studies con-
tains CryIA and CryIIA protoxins (packaged into crystals) as
well as spores. Our results document that the RRs for the
CryIC inclusion bodies (containing protoxin) were substan-
tially lower than those for the CryIC toxin, suggesting that
development of resistance to protoxin or HD-1 should be less
likely to occur. Moar et al. (16) and Moar (13a) have shown
that HD-1 spores are highly synergistic against S. exigua when
the spores are combined with a mixture of CryIA-CryIIA pro-
teins from HD-1 or the E. coli-expressed CryIA(b) from HD-1.
Our results demonstrate that HD-1 spores and CryIIA also
have synergistic activity against susceptible S. exigua, suggest-
ing that another mode of action or mechanism is involved in
the spore-toxin interaction. Therefore, another mutation or
gene(s) may be needed to confer resistance to HD-1 by S.
exigua. All recent reports of Lepidoptera that have evolved to
be resistant to B. thuringiensis indicate that resistance occurred
either in the field after repeated applications of B. thuringiensis
or with field-collected insects selected in the laboratory to be
TABLE 4. Cross-resistance of CryIC-resistant S. exigua to other Cry proteins from B. thuringiensis
Generationa Toxinb nc LC50(95% FL)d
Slope
(mean 6 SE) RR
e
20 CryIA(b) 92 NDf ND (20)
Susc. 86 25.3 (7.2–41.7) 1.70 6 0.47
22 CryIA(b) 96 5,866g 0.46 6 0.37 93
Susc. 96 63.2 (39.3–112) 1.37 6 0.34
34 CryIIA 258 10,731g 1.15 6 0.40 73
Susc. 282 147 (4.9–471) 0.86 6 0.22
34 CryIH 53 51% mortality at 80 mg/g 12
Susc. 409 6.6 (3.8–8.9) 2.93 6 0.45
a Generation of S. exigua selected with CryIC toxin beginning with generation 14. Susc., susceptible.
b All proteins used were toxins except CryIIA (protoxin).
c Total number of insects tested (one to three replicates with one to five concentrations).
d LC50s are in micrograms of protein per gram of diet or percent mortality at highest concentration tested. FL, fiducial limits.
e LC50 for the selected generation divided by the LC50 for the susceptible colony. Numbers in parentheses represent the RR when the LC50 was assumed to be at
the highest concentration tested.
f ND, not determined. Random 20 to 25% mortality among all concentrations tested; highest concentration, 500 mg of toxin per g of diet.
g Fiducial limits could not be generated.
TABLE 5. Cross-resistance of HD-133 CryIC-resistant S. exigua to other CryIC-type toxins from B. thuringiensis
Populationa Toxin nb LC50 (95% FL)c
Slope (mean
6 SE) RR
d
Res. CryIC 205 25% mortality at 320 mg/g (12.8)
Susc. HD-133 717 6.2 (5.3–7.4) 1.50 6 0.09
Res. CryIC 107 68.8 (68.8–NDe) 0.5 6 0.21 80
Susc. 60.5 98 0.86 (0.23–1.67) 1.06 6 0.26
Res. G27 122 73.6f 0.38 6 0.28 32
Susc. 113 2.28f 0.67 6 0.27
a Bioassays conducted with HD-133 CryIC-resistant S. exigua generation 29. Res., resistant; Susc., susceptible.
b Total number of insects tested (one to three replicates with one to five concentrations). HD-133 replicates were not bioassayed concurrently with 60.5 and G-27.
c LC50s are in micrograms of toxin per gram of diet or percent mortality at the highest concentration tested. FL, fiducial limits.
d LC50 for the selected generation divided by the LC50 for the susceptible colony. Numbers in parentheses represent the RR when the LC50 was assumed to be at
the highest concentration tested.
e ND, not determined.
f The highest concentration tested was 39 mg of G27 per g of diet. Fiducial limits could not be generated.
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resistant to B. thuringiensis. Therefore, our inability to develop
resistance to HD-1 still may be due to limited genetic hetero-
geneity (often associated with laboratory colonies which are
small relative to field populations) or some other field-related
factor. Given the fact that we did achieve high levels of resis-
tance with the CryIC toxin in S. exigua, this seems surprising.
S. exigua can evolve to be resistant to purified CryIC inclu-
sion bodies (containing protoxin) as well as toxin, although the
RRs for the inclusion bodies were generally low. These results
are the fourth example of resistance to Cry proteins by insect
species belonging to the family Noctuidae. H. virescens was
selected in the laboratory for resistance to inclusion bodies
containing CryIA(c) protoxin (8, 27). Estada and Ferre (5)
reported selection of CryIA(b) resistance by T. ni in the labo-
ratory. More recently, Mu¨ller-Cohn et al. (18) reported the
selection of CryIC protoxin resistance by S. littoralis in the
laboratory. However, parameters associated with resistance
such as cross-resistance to other Cry toxins and toxin binding
(to BBMVs) are not consistent among all four insect species.
Resistance parameters in S. exigua are similar to those re-
ported by Gould et al. (8) for H. virescens in that both species
are cross-resistant to all other Cry toxins tested. S. littoralis
insects resistant to CryIC also were resistant to CryID and
CryIE. However, CryIA(b)-resistant T. ni were susceptible to
CryIA(c). Furthermore, the dramatic decrease in receptor
binding observed for CryI-resistant P. interpunctella and P.
xylostella has not been observed in H. virescens and S. exigua (6,
8, 12, 34). Although Gould et al. (8) reported no difference in
binding affinity between susceptible and CryIA(c)-resistant H.
virescens, Macintosh et al. (12) did report a two- to fourfold
decrease in binding affinity for the same species. Although the
results from those two reports are still similar compared with
those for P. interpunctella and P. xylostella, our results would
more closely match the observations of Macintosh et al. (12).
Estada and Ferre (5) report that, on the basis of binding site
models, CryIA(b) and CryIA(c) should have bound to the
same high-affinity binding site, even though resistance to
CryIA(b) did not confer resistance to CryIA(c).
Binding studies with CryIC toxin indicated changes in the
brush border membrane of S. exigua larvae which showed 100-
to 500-fold resistance to CryIC toxin. Of interest is that CryIC-
resistant S. exigua insects also were resistant to G27, a fusion
protein in which domain III of CryIC is transferred to CryIE
(which is nontoxic to S. exigua). In S. exigua, CryIE and G27
bind to a receptor different from that to which CryIC binds (3).
Additionally, BBMVs from S. exigua have been shown to con-
tain multiple Cry binding proteins (20). The proteins (molec-
ular mass) that bind CryIC (40 kDa) were different from the
proteins that bind CryIA(b) (180 and 200 kDa) and CryIA(c)
(110 and 130 kDa). Therefore, while changes in binding cor-
relate with CryIC resistance, the changes are more complex
than a simple reduction in binding affinity.
There is a similarity between the characteristics of CryIC
binding in resistant S. exigua and susceptible H. virescens.
CryIC has a relatively low level of toxicity to H. virescens larvae
FIG. 1. CryIC binding to S. exigua BBMVs. (A) Binding of 125I-labeled
CryIC toxin as a function of vesicle concentration. The indicated vesicle concen-
trations of a susceptible strain (E) or a resistant strain (F) were incubated with
0.1 nM 125I-labeled CryIC toxins. (B) Competition of 125I-labeled CryIC binding
by unlabeled CryIC toxins. 125I-labeled CryIC toxin (0.1 nM) was incubated with
vesicles from susceptible (E) or resistant (F) strains in the presence of the
indicated concentrations of unlabeled CryIC toxins. Binding is expressed as a
percentage of the maximum amount of toxin bound upon incubation with labeled
toxin alone. The binding parameters (mean 6 standard error) estimated by
LIGAND analysis are presented in the inset. Kd and Bmax values are calculated
from two homologous competition experiments, performed on two indepen-
dently prepared batches of vesicles. Kd is expressed in nanomolar concentrations,
and Bmax is expressed in picomoles per milligram of vesicle protein. For both
panels, each point is the mean of two binding experiments. Standard errors are
shown by bars.
TABLE 6. Interactions of HD-1 spore with CryIC and CryIIA from
B. thuringiensis against susceptible and CryIC-resistant S. exigua
Toxin
% Mortalitya
Resistantb Susceptible
Sporec 4 (0–22) 6 (0–12)
CryICd 0 (0–0) 8 (5–15)
CryIIAe 2.5 (0–7) 17 (3–37)
Spore 1 CryICc,d 45 (35–54)f 90 (86–94)f
Spore 1 CryIIAc,e 55 (50–62)f 90 (84–100)f
a Bioassays were replicated three times; values in parentheses represent
ranges. See footnotes b to d for concentrations.
b Resistant were insects taken from generation 35.
c A total of 100 mg of HD-1 spore per g of diet.
d A total of 1.0 and 20 mg of CryIC toxin per g of diet for susceptible and
resistant insects, respectively.
e A total of 500 mg of CryIIA protoxin per g of diet.
f Synergistic activity (P , 0.05).
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(as observed for our CryIC-resistant larvae) (33). Similar to the
present study, total binding to H. virescens BBMV is roughly
40% of that to susceptible species Manduca sexta and S. litto-
ralis (33). A difference between our study and that of Van Rie
et al. (33) is that we measured a Kd of 8.5 nM for resistant S.
exigua and Van Rie et al. (33) reported a Kd of 22 nM for the
high-affinity site in H. virescens. Therefore, differences in total
binding of CryIC (specific and nonspecific) do not adequately
explain differences in susceptibility.
Vesicles prepared from resistant insects had an increased
level of nonspecific binding compared with those from suscep-
tible insects. This is defined as the inability of unlabeled CryIC
to compete with 125I-labeled CryIC for binding sites. The re-
lationship between nonspecific binding and toxicity is not
known. Luo and Adang (11) observed an increase in nonspe-
cific CryIC binding when CryIC had adhering subtoxin pep-
tides. While Gould et al. (8) reported no significant differences
in CryIA(b) binding to resistant H. virescens larvae, an inspec-
tion of their CryIA(b) binding curve to cross-resistant H. vire-
scens BBMVs shows a twofold increase in nonspecific binding.
If nonspecific binding interferes or competes with specific
high-affinity binding and reduces pore formation, nonspecific
binding could be a factor in resistance to toxins.
Explanations other than receptor binding have been impli-
cated in resistance to B. thuringiensis in at least one other insect
species. P. interpunctella insects that were resistant to B. thu-
ringiensis subsp. entomocidus and CryIC had a fivefold reduc-
tion in proteolytic activity against a synthetic trypsin substrate,
a-N-benzoyl-DL-arginine p-nitroanilide, and activated CryIA(c)
and CryIC protoxins at a reduced rate (21). This result suggests
that insects should be more resistant to protoxin than to toxin
because of a decrease in proteolysis. Our results support just
the opposite hypothesis. However, altered proteases that rec-
ognize other sites within the polypeptide could cleave critical
areas of the protein, rendering it nontoxic.
Bai and Degheele (1) reported that insects which were more
tolerant to B. thuringiensis subsp. thuringiensis crystals (such as
S. littoralis) had reduced concentrations of regurgitated gut
juice protein. They suggest that higher levels of proteinases
may facilitate the digestion of the crystal proteins. Bai et al. (2)
reported that S. littoralis gut juice contained only about 50% of
total protease activity compared with that in the gut juice of P.
brassicae and contained about six times less chymotrypsin-like
activity and about five times less trypsin-like activity compared
with those in the gut juice of P. brassicae. Therefore, Spodopt-
era spp. may be inherently more tolerant to Cry proteins be-
cause of their inability to digest Cry protoxins. Although one
mechanism of resistance may be reduced proteolysis, other
unknown mechanisms or explanations may exist.
Our recent experiments suggest that insects transferred from
toxin-treated to untreated diet lose some of their resistance to
Cry proteins. Because most B. thuringiensis resistance studies
select for resistance of insects on a treated diet and then
transfer larvae onto an untreated diet after about 5 days to
continue development (and for extracting BBMVs), the differ-
ences observed in total and high-affinity binding in our study
may be due to a relatively quick reversion to the normal phys-
iological status. On-going studies will determine if binding
parameters are different between insects selected on a treated
diet for the entire larval period compared with the typical
approach of selecting on a treated diet for only 5 days.
HD-1 spores have synergistic activity with CryIC and CryIIA
against CryIC-resistant and susceptible S. exigua. Because only
8% mortality was observed for the CryIC-resistant population
at 320 mg/g for generation 35 (a concentration 16-fold greater
than that used in the present joint-action test), an increase in
mortality to 45% (for the CryIC–HD-1 spore interaction) is
probably of more interest than the increase in mortality to 90%
for the susceptible population. HD-1 spores have been shown
to act synergistically with Cry toxins against S. exigua, but
spores from an HD-1 (Cry2) strain do not (13a, 16). This
suggests that compounds (or other mechanisms) other than
Cry toxins liberated from inclusion bodies are involved and
that selection for CryIC resistance does not select for concom-
itant resistance to the HD-1 spore.
Resistance to CryIC was observed even after 12 generations
without selection, although the resistance ratio appears to be
decreasing in comparison with that for S. exigua raised for
consecutive generations with CryIC resistance selection. Our
CryIC-resistant population was lost after generation 36 be-
cause of a viral epizootic. However, a population of reversion
10 was reselected with 320 mg of CryIC per g of diet. Most
larvae survived, suggesting that resistance was easily reestab-
lished, as has been documented for P. interpunctella (30). Mu¨l-
ler-Cohn et al. (18) reported that fitness parameters such as
pupal weight, sex ratio, and developmental time for CryIC-
TABLE 7. Stability of S. exigua resistance to the CryIC toxin of B. thuringiensis
Generationa nb LC50 (95% FL)c
Slope
(mean 6 SE) RR
d
7 68 76% mortality at 320 mg/g NDe ND
Susc. 477 1.0 (0.7–1.2) 2.12 6 0.22
34 (resistant) 69 53% mortality at 320 mg/g ND (330)
8 211 252 (150–1037) 1.92 6 0.52 23
Susc. 135 11.2 (5.1–158) 2.37 6 0.65
35 (resistant) 80 8% mortality at 320 mg/gf ND (29)
12 20 30% at 320 mg/g ND ND
3 (resistant)g 22 0% at 320 mg/g ND ND
a Insect generations were reared on an untreated diet after being taken from generation 29 of the CryIC toxin-resistant colony. Susc., susceptible.
b Total number of insects tested (one to three replicates with one to eight concentrations).
c LC50s are in micrograms of CryIC toxin per gram of diet or percent mortality at the highest concentration tested. FL, fiducial limits.
d LC50 for the selected generation divided by the LC50 for the susceptible colony. Numbers in parentheses represent the RRs when the LC50 was assumed to be at
the highest concentration tested.
e ND, not determined.
f Not concurrent.
g Resistant colony from generation 10 of reversion colony.
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resistant S. littoralis were the same as those for susceptible
insects. Preliminary observations with our CryIC-resistant S.
exigua population agree with those of Mu¨ller-Cohn et al. (18),
although these observations have not yet been quantified. Low
observable fitness costs therefore would increase the likelihood
of resistance in the field.
S. exigua is a major pest of many crops and will probably be
increasingly exposed to formulations of B. thuringiensis or
transgenic plants that express B. thuringiensis toxin. Our re-
search documents that resistance to an activated toxin may be
more easily achieved than resistance to inclusion bodies con-
taining protoxin, although continuous laboratory selection was
required for at least seven generations. Furthermore, resis-
tance to a spore-crystal mixture could not be achieved. Resis-
tance to one toxin conferred cross-resistance to most, if not all,
available Cry toxins. These results suggest that use of individ-
ual protoxins or toxins, especially as expressed in transgenic
organisms, could induce resistance in field populations more
readily than formulated materials containing multiple Cry pro-
teins and spores. Strategies which exploit mechanisms other
than changes in receptor binding will need to be pursued in
order to continue the use of B. thuringiensis.
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